mitomycin has been researched along with rifampin in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.14) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 2 (14.29) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 2 (14.29) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chopra, S; Choudhari, AS; Dusthackeer, VNA; Gaikwad, VR; Karale, UB; Krishna, EV; Krishna, VS; Mahizhaveni, B; Misra, S; Rode, HB; Sarkar, D; Shukla, M; Sriram, D | 1 |
Bangalore, PK; Bollikanda, RK; Choudante, PC; Kantevari, S; Misra, S; Sridhar, B; Sriram, D; Vagolu, SK; Veeragoni, DK | 1 |
Chhibber, S; Vadehra, DV | 1 |
Chahal, R; Craig, DQ; Pinney, RJ | 1 |
Cheng, CM; Huang, HJ; Kuo, TT; Lin, SH; Yang, BC; Yang, CC | 1 |
Barrow, E; Barrow, WW; Flavin, MT; Lin, YM; Suling, WJ; Westbrook, L; Xu, ZQ | 1 |
Jalava, J; Kuipers, OP; Savijoki, K; Varhimo, E; Varmanen, P | 1 |
Bhatter, P; Chatterjee, A; Mistry, N | 1 |
Bock, M; Bruun, NE; Bundgaard, H; Christensen, JJ; Christiansen, U; Elming, H; Fosbøl, EL; Fuursted, K; Gill, S; Helweg-Larsen, J; Høfsten, DE; Høiby, N; Ihlemann, N; Iversen, K; Køber, L; Moser, C; Povlsen, JA; Pries-Heje, MM; Rosenvinge, FS; Schwartz, F; Torp-Pedersen, C; Tønder, N; Van Hasselt, JGC; Wang, H | 1 |
1 review(s) available for mitomycin and rifampin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for mitomycin and rifampin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles; Tuberculosis, Multidrug-Resistant | 2019 |
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacillus subtilis; Benzofurans; Lichens; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Triazoles | 2020 |
Effect of various inducing agents on bacteriocin (klebocin) production by Klebsiella pneumoniae.
Topics: Bacteriocins; Chloramphenicol; Klebsiella pneumoniae; Mitomycin; Mitomycins; Polymyxin B; Rifampin; Ultraviolet Rays | 1987 |
Investigation of potential genotoxic effects of low frequency electromagnetic fields on Escherichia coli.
Topics: DNA Damage; DNA Repair; Electromagnetic Fields; Escherichia coli; Mitomycin; Mutagenesis; Mutagens; Plasmids; Rifampin; Ultraviolet Rays | 1993 |
Rapid inhibition of protein histidine phosphorylation by UV-irradiation in Xanthomonas oryzae pv. oryzae.
Topics: Bacterial Proteins; DNA Damage; DNA Repair; DNA Replication; DNA, Bacterial; Histidine; Kinetics; Mitomycin; Molecular Weight; Phosphoproteins; Rifampin; Ultraviolet Rays; Xanthomonas | 1995 |
Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
Topics: Animals; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Cisplatin; Coumarins; DNA; Drug Resistance, Bacterial; Ifosfamide; Inhibitory Concentration 50; Macrophages; Microbial Sensitivity Tests; Mitomycin; Mycobacterium tuberculosis; Pyranocoumarins; Rifampin; RNA; Vero Cells; Virus Replication | 2004 |
Identification of a novel streptococcal gene cassette mediating SOS mutagenesis in Streptococcus uberis.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; Blotting, Northern; Ciprofloxacin; DNA Damage; Drug Resistance, Bacterial; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Bacterial; Genes, Bacterial; Mitomycin; Models, Genetic; Molecular Sequence Data; Mutagenesis; Mutation; Operon; Rifampin; Sequence Homology, Nucleic Acid; SOS Response, Genetics; Streptococcus; Ultraviolet Rays | 2007 |
Kinetics of recA and recX induction in drug-susceptible and MDR clinical strains of Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Gene Expression; Gene Expression Profiling; Mitomycin; Mycobacterium tuberculosis; Real-Time Polymerase Chain Reaction; Rec A Recombinases; Rifampin; Transcriptional Activation | 2014 |
Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis.
Topics: Anti-Bacterial Agents; Endocarditis, Bacterial; Humans; Linezolid; Mitomycin; Rifampin | 2023 |